Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05122962 · ClinicalTrials.gov registry record
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
A clinical trial of Congenital Heart Disease and Tetralogy of Fallot, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05122962 is a study of Congenital Heart Disease and Tetralogy of Fallot that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 300 participants, below the 469-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05122962, a study of Congenital Heart Disease and Tetralogy of Fallot, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Remote Heart Rhythm Monitoring
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05122962
The ClinicalTrials.gov registry entry for NCT05122962 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 469-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (36% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Remote Heart Rhythm Monitoring is the first listed.
NCT05122962 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05122962 about?
NCT05122962 is a clinical study titled "Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases". This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)
What is the current status of trial NCT05122962?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-11-01. Estimated completion is 2026-10.
What conditions does trial NCT05122962 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Tetralogy of Fallot.
What interventions are being tested in trial NCT05122962?
The interventions under investigation include: Remote Heart Rhythm Monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05122962?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05122962 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.